US Launches Formal Inquiry Into German Pharma Pricing Policies Amid Trade Tensions
The United States has initiated a formal investigation into Germany's pharmaceutical pricing regulations, citing unfair trade practices. The probe could result in new tariffs under Section 301, escalating trade tensions between Washington and Berlin.